$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000087786018000060 Filed on August 07, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$72.96M	$69.84M
YoY Change	4.47%	14.1%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.250M	$2.930M
YoY Change	10.92%	16.27%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.79M	$16.82M
YoY Change	5.8%	14.45%
% of Gross Profit
Operating Expenses	$35.12M	$31.49M
YoY Change	11.54%	-26.1%
Operating Profit	$37.84M	$38.34M
YoY Change	-1.31%	106.13%
Interest Expense	$12.22M	$11.73M
YoY Change	4.16%	9.99%
% of Operating Profit	32.29%	30.6%
Other Income/Expense, Net
YoY Change
Pretax Income	$37.84M	$38.24M
YoY Change	-1.05%	105.59%
Income Tax
% Of Pretax Income
Net Earnings	$37.84M	$38.25M
YoY Change	-1.06%	-14.24%
Net Earnings / Revenue	51.87%	54.76%
Basic Earnings Per Share	$0.91	$0.93
Diluted Earnings Per Share	$0.91	$0.93
COMMON SHARES
Basic Shares Outstanding	41.70M shares	40.98M shares
Diluted Shares Outstanding	41.79M shares	41.25M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.000M	$3.926M
YoY Change	-23.59%	-85.79%
Cash & Equivalents	$2.638M	$3.926M
Short-Term Investments		$0.00
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$9.700M	$3.800M
Other Receivables	$108.8M	$83.20M
Total Short-Term Assets	$121.5M	$90.50M
YoY Change	34.25%	29.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.389B	$2.267B
YoY Change	5.37%	9.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.200M	$4.400M
YoY Change	18.18%	-48.84%
Total Long-Term Assets	$2.552B	$2.421B
YoY Change	5.42%	6.84%
TOTAL ASSETS
Total Short-Term Assets	$121.5M	$90.50M
Total Long-Term Assets	$2.552B	$2.421B
Total Assets	$2.673B	$2.511B
YoY Change	6.46%	7.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.80M	$18.30M
YoY Change	-8.2%	-30.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$80.30M	$79.60M
YoY Change	0.88%	-3.75%
LONG-TERM LIABILITIES
Long-Term Debt	$1.226B	$1.145B
YoY Change	7.05%	6.73%
Other Long-Term Liabilities	$5.800M
YoY Change
Total Long-Term Liabilities	$1.232B	$1.145B
YoY Change	7.55%	6.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.30M	$79.60M
Total Long-Term Liabilities	$1.232B	$1.145B
Total Liabilities	$1.312B	$1.225B
YoY Change	7.12%	5.86%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.334B	$1.255B
YoY Change	6.32%	10.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.361B	$1.286B
YoY Change
Total Liabilities & Shareholders Equity	$2.673B	$2.511B
YoY Change	6.46%	7.52%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	$37.84M	$38.25M
YoY Change	-1.06%	-14.24%
Depreciation, Depletion And Amortization	$17.79M	$16.82M
YoY Change	5.8%	14.45%
Cash From Operating Activities	$53.30M	$46.20M
YoY Change	15.37%	10.26%
INVESTING ACTIVITIES
Capital Expenditures	-$115.2M	-$10.40M
YoY Change	1007.69%	-95.87%
Acquisitions
YoY Change
Other Investing Activities	-$6.100M	$2.900M
YoY Change	-310.34%	-91.92%
Cash From Investing Activities	-$121.3M	-$7.500M
YoY Change	1517.33%	-96.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	67.90M	-41.00M
YoY Change	-265.61%	-127.44%
NET CHANGE
Cash From Operating Activities	53.30M	46.20M
Cash From Investing Activities	-121.3M	-7.500M
Cash From Financing Activities	67.90M	-41.00M
Net Change In Cash	-100.0K	-2.300M
YoY Change	-95.65%	-90.76%
FREE CASH FLOW
Cash From Operating Activities	$53.30M	$46.20M
Capital Expenditures	-$115.2M	-$10.40M
Free Cash Flow	$168.5M	$56.60M
YoY Change	197.7%	-80.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	2.00
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42174948	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTH INVESTORS INC
CY2017Q4	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	5187000	USD
CY2018Q2	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	9709000	USD
CY2017Q2	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	868000	USD
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1774000	USD
CY2018Q2	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	777000	USD
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1612000	USD
CY2017Q2	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	0.95
	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	1.90
CY2018Q2	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	1.00
	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	25000	shares
	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-26000	USD
CY2018Q2	nhi	Contingent Funding Commitment ContingentFundingCommitment	34850000	USD
CY2018Q2	nhi	Contingent Funding Commitment Remaining Unfunded Amount ContingentFundingCommitmentRemainingUnfundedAmount	29350000	USD
CY2018Q2	nhi	Credit Facility Current Revolving Borrowing Capacity CreditFacilityCurrentRevolvingBorrowingCapacity	550000000	USD
	nhi	Debt Instrument Variable Rate Basis Minimum DebtInstrumentVariableRateBasisMinimum	0.00
CY2017Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	267000	USD
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	534000	USD
CY2018Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	266000	USD
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	612000	USD
CY2017Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	1250000	USD
CY2018Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	3775000	USD
CY2017Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
CY2018Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1849000	USD
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1849000	USD
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1849000	USD
CY2018Q2	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	28579000	USD
CY2018Q2	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	2471000	USD
CY2018Q2	nhi	Notes Receivable Funding Commitment NotesReceivableFundingCommitment	36717000	USD
CY2018Q2	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	10	properties
CY2018Q2	nhi	Number Of Lessees NumberOfLessees	29
CY2018Q2	nhi	Real Estate Investment Property Portfolio Assets RealEstateInvestmentPropertyPortfolioAssets	2801479000	USD
	nhi	Real Estate Investments During The Period RealEstateInvestmentsDuringThePeriod	130294000	USD
	nhi	Redemptionsof Convertible Debt Total Expenditures Debt Allocation RedemptionsofConvertibleDebtTotalExpendituresDebtAllocation	27558000	USD
CY2018Q2	nhi	Remaining Unfunded Development Commitment RemainingUnfundedDevelopmentCommitment	12998000	USD
CY2018Q2	nhi	Variable Interest Entity Number Of Entities Not Primary Beneficiary VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary	8
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	16302000	USD
CY2018Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	16814000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	380202000	USD
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	415332000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-822000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2138000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1289919000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1333874000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	325000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	-2427000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1865000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1794000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	349000	USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	589000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2479000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2100000	USD
	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	20000	USD
	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	132000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11015	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9736	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33554	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50952	shares
CY2017Q4	us-gaap	Assets Assets	2545821000	USD
CY2018Q2	us-gaap	Assets Assets	2673236000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4832000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3470000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3063000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3045000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1362000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.00
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41532154	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42171866	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41532154	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42171866	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	415000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	422000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	38200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	73620000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	38642000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	78996000	USD
	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	15581000	USD
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2678000	USD
CY2018Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	5093000	USD
CY2014Q1	us-gaap	Convertible Debt ConvertibleDebt	192238000	USD
CY2017Q4	us-gaap	Convertible Debt ConvertibleDebt	144938000	USD
CY2018Q2	us-gaap	Convertible Debt ConvertibleDebt	118229000	USD
CY2017Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	32605000	USD
CY2018Q2	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	24938000	USD
CY2018Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1237846000	USD
CY2014Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	7762000	USD
CY2018Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	69.79
	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	6693000	USD
	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	1719500	shares
CY2018Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.039
CY2018Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3132000	USD
CY2017Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1145497000	USD
CY2018Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1225720000	USD
CY2017Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	97359000	USD
CY2018Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	108771000	USD
CY2017Q4	us-gaap	Deferred Revenue DeferredRevenue	1174000	USD
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.03
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1339000	USD
CY2018Q2	us-gaap	Deferred Revenue DeferredRevenue	5833000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	16819000	USD
	us-gaap	Depreciation Depreciation	32963000	USD
CY2018Q2	us-gaap	Depreciation Depreciation	17794000	USD
	us-gaap	Depreciation Depreciation	35129000	USD
CY2017Q2	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	645000	USD
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	1434000	USD
CY2018Q2	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	76000	USD
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	352000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	83703000	USD
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	39456000	USD
CY2018Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	42172000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.04
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.83
CY2017Q4	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
CY2018Q2	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
CY2017Q2	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	10088000	USD
CY2018Q2	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	50000	USD
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-96000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-96000	USD
CY2018Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-738000	USD
CY2016Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	USD
CY2017Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	50000	USD
CY2017Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	USD
CY2018Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2521000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6630000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2765000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6935000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.93
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.04
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.91
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.83
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.93
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.03
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.91
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.83
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	283000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2900000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2321000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5759000	USD
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	196792	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	147420	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	24251	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	12126	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	66137	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	63901	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	57759	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	51241	shares
CY2018Q2	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	3056000	USD
	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	6516000	USD
CY2017Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	93000	USD
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	160000	USD
CY2018Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	47000	USD
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	71000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	11732000	USD
	us-gaap	Interest Expense InterestExpense	23393000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	12220000	USD
	us-gaap	Interest Expense InterestExpense	23834000	USD
CY2017Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10312000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	20345000	USD
CY2018Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	11414000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	21941000	USD
CY2017Q2	us-gaap	Interest Income Operating InterestIncomeOperating	4101000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	7352000	USD
CY2018Q2	us-gaap	Interest Income Operating InterestIncomeOperating	3087000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	6580000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	21667000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	22403000	USD
CY2018Q2	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	787000	USD
CY2017Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2471602000	USD
CY2018Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2598660000	USD
CY2017Q4	us-gaap	Land Land	191623000	USD
CY2018Q2	us-gaap	Land Land	200197000	USD
CY2017Q2	us-gaap	Legal Fees LegalFees	146000	USD
	us-gaap	Legal Fees LegalFees	202000	USD
CY2018Q2	us-gaap	Legal Fees LegalFees	223000	USD
	us-gaap	Legal Fees LegalFees	334000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	1223704000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	1311864000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2545821000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2673236000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1256000	USD
	us-gaap	Loss On Cash Flow Hedge Ineffectiveness LossOnCashFlowHedgeIneffectiveness	353000	USD
CY2016Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2017Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	10038000	USD
CY2017Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	221000000	USD
CY2018Q2	us-gaap	Line Of Credit LineOfCredit	327000000	USD
CY2018Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	800000000	USD
	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	20
	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	117000000	USD
CY2017Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	141486000	USD
CY2018Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	149676000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	1166000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	409561000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	703353000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	121303000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	1207000	USD
CY2018Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	10038000	USD
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31601000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39054000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127911000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-140897000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	94948000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	101825000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	38245000	USD
	us-gaap	Net Income Loss NetIncomeLoss	82475000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	37839000	USD
	us-gaap	Net Income Loss NetIncomeLoss	76271000	USD
CY2018Q2	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	235000	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	598000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	273000	USD
CY2018Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	219	properties
CY2018Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	33
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	31485000	USD
	us-gaap	Operating Expenses OperatingExpenses	63722000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	35117000	USD
	us-gaap	Operating Expenses OperatingExpenses	68693000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	38341000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	72483000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	37839000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	77009000	USD
CY2017Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	65725000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	128853000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	2373000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2018Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	69869000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	139122000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	18212000	USD
CY2018Q2	us-gaap	Other Assets OtherAssets	23126000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8855000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	803000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2725000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	10038000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-645000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-1434000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-76000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-352000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-690000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-225000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	727000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Noncash Income OtherNoncashIncome	470000	USD
	us-gaap	Other Noncash Income OtherNoncashIncome	943000	USD
CY2016Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2017Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10088000	USD
CY2017Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2018Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2891000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	4269000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	74651000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	80988000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	360000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	325000	USD
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	30950000	USD
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	9845000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	128411000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	129558000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	8446000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	79772000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	44920000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	153000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	179000000	USD
	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	450000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	568000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2762000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	29985000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	123000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	73000000	USD
CY2017Q4	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	4817000	USD
CY2018Q2	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	5209000	USD
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	24155000	USD
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	2775000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18182000	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18182000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2665903000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2803950000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2285701000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2388618000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	394000	USD
CY2017Q2	us-gaap	Revenues Revenues	69826000	USD
	us-gaap	Revenues Revenues	136205000	USD
CY2018Q2	us-gaap	Revenues Revenues	72956000	USD
	us-gaap	Revenues Revenues	145702000	USD
	us-gaap	Sale Leaseback Transaction Transaction Costs Investing Activities SaleLeasebackTransactionTransactionCostsInvestingActivities	100000	USD
CY2017Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	21275000	USD
CY2018Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	21325000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1794000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.053
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.065
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.198
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.194
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0149
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0239
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	540830	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	854990	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.75
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.49
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	541679	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	934181	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	859182	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1310012	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y11M2D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y11M9D
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44920000	USD
CY2017Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	342000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1865000	USD
CY2018Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	368000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1794000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	1322117000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	1361372000	USD
	us-gaap	Straight Line Rent StraightLineRent	12005000	USD
	us-gaap	Straight Line Rent StraightLineRent	11797000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10453000	USD
CY2018Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8994000	USD
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	40982244	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	40468024	shares
CY2018Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	41704819	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	41618487	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41245173	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40679345	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41786829	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41681854	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40982244	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40468024	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41704819	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41618487	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:inherit;font-size:10pt;"> - We have reclassified certain balances where necessary to conform the presentation of prior periods to the current period. These reclassifications had no effect on previously reported net income.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates</font></div></div>

Files In Submission

Name	View Source	Status
0000877860-18-000060-index-headers.html	Edgar Link	pending
0000877860-18-000060-index.html	Edgar Link	pending
0000877860-18-000060.txt	Edgar Link	pending
0000877860-18-000060-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhi-20180630.xml	Edgar Link	completed
nhi-20180630.xsd	Edgar Link	pending
nhi-20180630_cal.xml	Edgar Link	unprocessable
nhi-20180630_def.xml	Edgar Link	unprocessable
nhi-20180630_lab.xml	Edgar Link	unprocessable
nhi-20180630_pre.xml	Edgar Link	unprocessable
nhi-6302018x10q.htm	Edgar Link	pending
nhi-6302018x10qex311.htm	Edgar Link	pending
nhi-6302018x10qex312.htm	Edgar Link	pending
nhi-6302018x10qex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

2018 Q2 Form 10-Q Financial Statement

#000087786018000060 Filed on August 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI NATIONAL HEALTH INVESTORS INC Stock $nhi

2018 Q2 Form 10-Q Financial Statement

#000087786018000060 Filed on August 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi